On June, 13 The EPS for Pharma-Bio Serv, Inc. (PBSV) Expected At $-0.01

May 17, 2018 - By Cristopher Snider

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Corporate Logo

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV)’s earnings report is expected on June, 13., Faxor reports. Last year’s EPS was $-0.01, while now analysts expect change of 0.00 % from current $-0.01 EPS. Lastly it traded at $0.6.It’s since May 17, 2017 and is 0.00% down. The stock underperformed the S&P500 by 11.55%.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil.The firm is worth $13.84 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support.Currently it has negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: